Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study
Abstract Background and Objectives Direct-acting antivirals (DAAs) offer a high rate of hepatitis C virus (HCV) eradication. However, concerns on the risk of cancer after HCV eradication remain. Our study aimed at quantifying the incidence of cancer in patients treated with anti-HCV therapies in Cat...
Saved in:
Main Authors: | José Ríos (Author), Víctor Sapena (Author), Zoe Mariño (Author), Jordi Bruix (Author), Xavier Forns (Author), Rosa Morros (Author), María Reig (Author), Ferran Torres (Author), Caridad Pontes (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Eradication Therapy Reduce the Incidence of Nonalcoholic Fatty Liver Disease?
by: Sun Hyung Kang
Published: (2022) -
Impact of Eradication on the Risk of Incident Nonalcoholic Fatty Liver Disease: A Cohort Study
by: Ji Won Kim, et al.
Published: (2022) -
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study
by: Valentina Cossiga, et al.
Published: (2022) -
Liver stiffness in chronic hepatitis C virus infection
by: Mihăilă Romeo-Gabriel
Published: (2019) -
Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
by: Xavier Woot de Trixhe, et al.
Published: (2021)